| SHARE BASED COMPENSATION |
Note 10: - SHARE BASED COMPENSATION
| a. | A summary of the stock option activity under the Company’s equity plans during the six months ended June 30, 2026 is as follows: |
| | | Outstanding
share options | | | Weighted-
average
exercise
price ($) | | | Weighted
average
remaining
contractual life
(years) | | | Aggregate
intrinsic
value
($ in thousands) | |
| Options: | | | | | | | | | | | | |
| Outstanding as of December 31, 2025 | | | 4,083,497 | | | | 4.38 | | | | 5.53 | | | | 326,730 | |
| | | | | | | | | | | | | | | | | |
| Granted | | | - | | | | - | | | | | | | | | |
| Forfeited | | | (206,462 | ) | | | 3.728 | | | | | | | | | |
| Exercised | | | (75,470 | ) | | | 0.815 | | | | | | | | | |
| Outstanding as of June 30, 2026 | | | 3,801,565 | | | | 4.486 | | | | 5.856 | | | | 199,314 | |
| | | | | | | | | | | | | | | | | |
| Exercisable as of June 30, 2026 | | | 3,453,222 | | | | 4.713 | | | | 4.552 | | | | 199,314 | |
| | | | | | | | | | | | | | | | | |
| Options and RSUs available for future grants | | | 2,369,274 | | | | | | | | | | | | | |
A summary of the Company’s RSUs activity during the six months ended June 30, 2026 is as follows:
| | | Numbers of
RSUs | |
| RSUs: | | | |
|
Outstanding as of December 31, 2025
| | | 3,143,418 | |
| Granted | | | 3,527,125 | |
| Forfeited | | | (178,437 | ) |
| Vested | | | (2,331,411 | ) |
| Outstanding as of June 30, 2026 | | | 4,160,695 | |
No options were granted during the six months ended June 30, 2026 and 2025.
| c. | The following table presents share-based compensation expense for employees included in the Company’s consolidated statements of operations: |
| | |
Six months ended
June 30,
| |
| | | 2026 | | | 2025 | |
| | | | | | | |
| Research and development | | | 1,624 | | | | 3,702 | |
| Sales and marketing | | | 177 | | | | 930 | |
| General and administrative | | | 390 | | | | 849 | |
| Cost of revenues | | | 31 | | | | 92 | |
| | | | | | | | | |
| Total stock-based compensation expense | | | 2,222 | | | | 5,573 | |
Share-based compensation expenses are not deductible for Israeli income tax purposes, and therefore the Company did not recognize any tax benefits related to the share-based compensation for the six months ended June 30, 2026 and 2025. During the six months ended June 30, 2026 and 2025, the Company recognized the total fair value of warrants issued to non-employee service providers of $91 and $364, respectively.
|